Does the Indian variant of Sars-CoV-2, B1.617.2, have the capacity to escape vaccines? Is it really more transmissible than the Kent variant, and by how much? Those are the urgent questions which government scientific advisers are going to have to try to answer over the next week or two – and the answers will have profound consequences for life in Britain over the next few months.
Already a subscriber? Log in
Get 10 issues
for $10
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in